Chronische PF-ILD: G-BA bescheinigt Zusatznutzen für Nintedanib
Crossref DOI link: https://doi.org/10.1007/s15002-021-3255-x
Published Online: 2021-04-29
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2021-04-01
Version of Record valid from 2021-04-01
Article History
First Online: 29 April 2021
Free to read: This content has been made available to all.